Brief: Rovi Sees 200-300 Mln Euros Potential Risperidone Sales Globally In Upcoming Years
24/06/2024 09:12
June 24 (Reuters) - Laboratorios Farmaceuticos ROVI SA
ROVI.MC :
* FORECASTS POTENTIAL RISPERIDONE ISM SALES OF BETWEEN 200
AND 300
MILLION EUROS GLOBALLY IN UPCOMING YEARS
Source text for Eikon: ID:nCNM2MDyV1
Further company coverage: ROVI.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))